175 results
Page 3 of 9
8-K
EX-99.1
cpr1 dzt6kwx62k9ci36
24 May 22
Departure of Directors or Certain Officers
7:30am
8-K
EX-99.1
4zkf9kyrqfk
12 May 22
Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-99.1
ky9i1px
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
424B5
6mo3ln
27 Apr 22
Prospectus supplement for primary offering
6:30am
8-K
EX-99.1
69r 2syskxdjpufoqr7
14 Apr 22
Regulation FD Disclosure
4:15pm
8-K
EX-99.1
prhijfue5 ld90p1jg
30 Mar 22
Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update
4:19pm
8-K
qj7vyw yza
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-99.2
6plblboucm
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-99.1
vb41u 3alm4pr2h
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
424B5
3lnq4
14 Mar 22
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.1
q126c2wn4 lp9
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
sj1yhqno zmrw
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
424B5
mgbu1
10 Jan 22
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
u7xw2bw
2 Nov 21
Agile Therapeutics Reports Third Quarter 2021 Financial Results
4:11pm